Bio-Techne Corp 2022 SR
The report highlights Bio-Techne's fiscal 2022 performance, surpassing $1.1 billion in revenue while advancing its ESG initiatives across four pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Key achievements include the disclosure of Scope 1 and 2 greenhouse gas emissions for the first time and the opening of a state-of-the-art GMP protein manufacturing facility. The company also emphasized its EPIC values, fostering a diverse workforce of nearly 3,000 employees and supporting 10 Employee Resource Groups. Bio-Techne was recognized by Forbes as one of America's Best Mid-Size Employers and Best Employers for Diversity in 2022.
Company: Bio-Techne Corp
Sector: Health Care
Country: United States
Year: 2022
Type: SR
Pages: 64
Back to company
Bio-Techne Corp
Corporate Sustainability Report
The report highlights Bio-Techne's fiscal 2022 performance, surpassing $1.1 billion in revenue while advancing its ESG initiatives across four pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Key achievements include the disclosure of Scope 1 and 2 greenhouse gas emissions for the first time and the opening of a state-of-the-art GMP protein manufacturing facility. The company also emphasized its EPIC values, fostering a diverse workforce of nearly 3,000 employees and supporting 10 Employee Resource Groups. Bio-Techne was recognized by Forbes as one of America's Best Mid-Size Employers and Best Employers for Diversity in 2022.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Fiscal Year 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees